top of page

Utilizing the consistent mechanism of induced hyper-osmosis, our proprietary platform employs the well-accepted pharmacological properties of NaCl. ​

Its inherent biocompatibility ensures a reliable safety profile, positioning our approach as both innovative and rooted in fundamental biochemistry.​

Approach 

Liita_logo_green_dark.png

We’re LIIRA CARE

Redefining respiratory self-care

Liita_logo_green_dark.png

Redefining respiratory self-care

LIITA Care is a late-stage biotech company dedicated to the discovery and development of novel therapies that improve the lives of consumers suffering from respiratory diseases

Our mission is to become a global provider of the future go-to solution for respiratory self-care. We do this by transforming the cough and cold category with our portfolio of clinically documented over-the-counter treatments

Our patented technology deploys NaCl microparticles in a new and consumer-friendly treatment form proven to be clinically beneficial in diseases that affect more than 80% of the world's population

Liita_logo_green.png

Our Product Pipeline

Diversified and innovative pipeline including late-stage assets open the opportunity for position as global go-to brand for NaCl particle inhalation

Liita_logo_green.png

Research

We are the first company in the world to introduce salt particle inhalation to the market.Thanks to our cutting edge research we are the company with the most extensive knowledge within inhaled salt therapy and respiratory disease.

We have scientific collaborations with the leading universities in the field.

Our research is supported by Innovation Fund Denmark. In 2020 we received a prestigious grand, Grand Solutions from Innovation Fund Denmark for scientific research in Covid-19.

We have been selected as the best in class in ERS Congress 2022 to present our latest, ground-breaking scientific discoveries regarding COVID-19 treatment.

Latest News

Catch up on the latest news & updates here

02 October 2020 • News Article

2025 Design Contest Winners Announced

This is your News article. It’s a great place to highlight press coverage, newsworthy stories, industry updates or useful resources for visitors.

02 October 2020 • News Article

2025 Design Contest Winners Announced

This is your News article. It’s a great place to highlight press coverage, newsworthy stories, industry updates or useful resources for visitors.

02 October 2020 • News Article

2025 Design Contest Winners Announced

This is your News article. It’s a great place to highlight press coverage, newsworthy stories, industry updates or useful resources for visitors.

Browse All News

Board member

Henrik Kjær Hansen

Novo Holdings

  • LinkedIn

Board member

Jakob Ottesen Thiesson

Boston Consulting Group

  • LinkedIn

Board member

Martin Røssberg

MR Law

  • LinkedIn

CEO & Founder

Martin Ohrt

LIITA Care

  • LinkedIn

CFO

Søren Kjær Henningsen

LIITA Care

  • LinkedIn
Board of Directors
Management
Liita_logo_green.png

Scientific Collaborations

LIITA has pushed the boundaries for medical science’s understanding of the health benefits of inhaled NaCl. Based on our proprietary state-of-the-art technology we are working with leading scientists and universities around the world aiming to expand this understanding even further. Please contact us for inquiries into potential collaborations.

bottom of page